When data were analyzed separately for study site clusters , a post hoc analysis demonstrated that both SPN-@ dosages were significantly superior to placebo in median percent seizure reduction ( placebo : -@ % ; @ mg : -@ % , P = @ ; @ mg : -@ % , P = @ ) in the North American study site cluster .